Business ❯ Pharmaceutical Industry ❯ Drug Sales

Market Competition

Eylea Sales Emerging Drugs Biosimilars Eli Lilly

Amgen Reports Repatha Cuts First-Event Risk in Primary-Prevention Trial

Full results will be unveiled Nov. 8 at the AHA meeting to guide payer coverage and prescribing.